Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
Dimitrios VenetsanosErik TräffDavid ErlingeEmil HagströmJohan NilssonLiyew DestaBertil LindahlLinda MellbinElmir OmerovicKarolina Elisabeth SzummerSammy ZwackmanTomas JernbergJoakim AlfredssonPublished in: Heart (British Cardiac Society) (2021)
In patients with MI treated with PCI, prasugrel and ticagrelor were associated with similar efficacy and safety during 1-year follow-up.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- heart failure
- left ventricular
- atrial fibrillation
- coronary artery bypass
- newly diagnosed